FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2275740045> ?p ?o ?g. }

• W2275740045 endingPage "240" @default.
• W2275740045 startingPage "230" @default.
• W2275740045 abstract "Recently, it is suggested that mTOR signaling pathway is an important mediator in many cancers especially breast cancer. Therefore, effects of sirolimus as a mTOR inhibitor in breast cancer have been studied in combination with paclitaxel with or without controlled release effect. In this work, we prepared a water-soluble formulation of sirolimus-conjugated albumin nanoparticles loaded with paclitaxel, to study the effects of sirolimus concentration when it releases more later than paclitaxel in comparison with sirolimus-paclitaxel-loaded albumin nanoparticles. Also effects of paclitaxel loading on cytotoxic properties of nanoparticles were studied. Sirolimus was succinylated at 42-OH with enzymatic reaction of Candida antarctica lipase B, and then its carboxylic group was activated with EDC/NHS and conjugated to the lysine residues of albumin. Paclitaxel was loaded on albumin surface by nab technique in concentration range of 0-10 μg/mL. Sirolimus-conjugated nanoparticles with 0.01 μg/mL paclitaxel showed lowest cell viability of 44% while it was 53% for non-conjugated nanoparticles in MDA-MB-468 cell lines after 48 h (p-value = 0.003). In MCF-7 cell lines, sirolimus-conjugated nanoparticles with 0.1 μg/mL paclitaxel showed lowest cell viability of 35.69% while it was 48% for non-conjugated nanoparticles after 48 h (p-value = 0.03). We guess that when cancer cell lines arrest in G2-M by anticancer drugs like paclitaxel, Akt activates mTOR to make cells continue living, then inhibiting mTOR can enhance anticancer effects." @default.
• W2275740045 created "2016-06-24" @default.
• W2275740045 creator A5001446567 @default.
• W2275740045 creator A5011518097 @default.
• W2275740045 creator A5012202031 @default.
• W2275740045 creator A5015899892 @default.
• W2275740045 creator A5030970197 @default.
• W2275740045 creator A5046888427 @default.
• W2275740045 creator A5069744121 @default.
• W2275740045 date "2016-03-31" @default.
• W2275740045 modified "2023-09-27" @default.
• W2275740045 title "Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel-loaded Sirolimus-conjugated Albumin Nanoparticles" @default.
• W2275740045 cites W1964578073 @default.
• W2275740045 cites W1978198019 @default.
• W2275740045 cites W1980352382 @default.
• W2275740045 cites W1985063806 @default.
• W2275740045 cites W1990034595 @default.
• W2275740045 cites W1998203489 @default.
• W2275740045 cites W2005120599 @default.
• W2275740045 cites W2037900100 @default.
• W2275740045 cites W2041192233 @default.
• W2275740045 cites W2048910214 @default.
• W2275740045 cites W2069513041 @default.
• W2275740045 cites W2073885879 @default.
• W2275740045 cites W2090356352 @default.
• W2275740045 cites W2094883350 @default.
• W2275740045 cites W2107436374 @default.
• W2275740045 cites W2116355318 @default.
• W2275740045 cites W2126718734 @default.
• W2275740045 cites W2129307474 @default.
• W2275740045 cites W2129585918 @default.
• W2275740045 cites W2144323242 @default.
• W2275740045 cites W2148836534 @default.
• W2275740045 cites W2152600551 @default.
• W2275740045 cites W2157754065 @default.
• W2275740045 cites W2170704593 @default.
• W2275740045 cites W4255762755 @default.
• W2275740045 doi "https://doi.org/10.1111/cbdd.12750" @default.
• W2275740045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26913996" @default.
• W2275740045 hasPublicationYear "2016" @default.
• W2275740045 type Work @default.
• W2275740045 sameAs 2275740045 @default.
• W2275740045 citedByCount "8" @default.
• W2275740045 countsByYear W22757400452017 @default.
• W2275740045 countsByYear W22757400452020 @default.
• W2275740045 countsByYear W22757400452022 @default.
• W2275740045 crossrefType "journal-article" @default.
• W2275740045 hasAuthorship W2275740045A5001446567 @default.
• W2275740045 hasAuthorship W2275740045A5011518097 @default.
• W2275740045 hasAuthorship W2275740045A5012202031 @default.
• W2275740045 hasAuthorship W2275740045A5015899892 @default.
• W2275740045 hasAuthorship W2275740045A5030970197 @default.
• W2275740045 hasAuthorship W2275740045A5046888427 @default.
• W2275740045 hasAuthorship W2275740045A5069744121 @default.
• W2275740045 hasConcept C109316439 @default.
• W2275740045 hasConcept C112613896 @default.
• W2275740045 hasConcept C121608353 @default.
• W2275740045 hasConcept C126322002 @default.
• W2275740045 hasConcept C1491633281 @default.
• W2275740045 hasConcept C178790620 @default.
• W2275740045 hasConcept C185592680 @default.
• W2275740045 hasConcept C202751555 @default.
• W2275740045 hasConcept C2777292972 @default.
• W2275740045 hasConcept C2777921159 @default.
• W2275740045 hasConcept C2780783641 @default.
• W2275740045 hasConcept C521977710 @default.
• W2275740045 hasConcept C53227056 @default.
• W2275740045 hasConcept C55493867 @default.
• W2275740045 hasConcept C62478195 @default.
• W2275740045 hasConcept C71924100 @default.
• W2275740045 hasConcept C86554907 @default.
• W2275740045 hasConcept C98274493 @default.
• W2275740045 hasConceptScore W2275740045C109316439 @default.
• W2275740045 hasConceptScore W2275740045C112613896 @default.
• W2275740045 hasConceptScore W2275740045C121608353 @default.
• W2275740045 hasConceptScore W2275740045C126322002 @default.
• W2275740045 hasConceptScore W2275740045C1491633281 @default.
• W2275740045 hasConceptScore W2275740045C178790620 @default.
• W2275740045 hasConceptScore W2275740045C185592680 @default.
• W2275740045 hasConceptScore W2275740045C202751555 @default.
• W2275740045 hasConceptScore W2275740045C2777292972 @default.
• W2275740045 hasConceptScore W2275740045C2777921159 @default.
• W2275740045 hasConceptScore W2275740045C2780783641 @default.
• W2275740045 hasConceptScore W2275740045C521977710 @default.
• W2275740045 hasConceptScore W2275740045C53227056 @default.
• W2275740045 hasConceptScore W2275740045C55493867 @default.
• W2275740045 hasConceptScore W2275740045C62478195 @default.
• W2275740045 hasConceptScore W2275740045C71924100 @default.
• W2275740045 hasConceptScore W2275740045C86554907 @default.
• W2275740045 hasConceptScore W2275740045C98274493 @default.
• W2275740045 hasIssue "2" @default.
• W2275740045 hasLocation W22757400451 @default.
• W2275740045 hasLocation W22757400452 @default.
• W2275740045 hasOpenAccess W2275740045 @default.
• W2275740045 hasPrimaryLocation W22757400451 @default.
• W2275740045 hasRelatedWork W1973972548 @default.
• W2275740045 hasRelatedWork W2089474763 @default.
• W2275740045 hasRelatedWork W2349009359 @default.

• next